About GreyScan

Our mission is to provide portable analytical screening tools for detection of trace amounts of substances using Capillary Zone Electrophoresis (CZE) within Security and Defence, Pharmaceutical Quality Control and Virus Detection.

About GreyScan

Who We Are

GreyScan® is an Australian technology company focused on the detection of inorganic material. Privately held, we are Melbourne based with a growing team of more than 25 scientists and technologists. 

Established in 2015, GreyScan was formed out of the Grey Innovation group of companies, which was primarly responsible for the commercialisation of the technology developed in conjunction with the University of Tasmania under Professor Michael Breadmore.  Since then, GreyScan has invested more than US$30 million to design, engineer, commercialise and mass produce the portable CZE platform that forms the basis of all GreyScan products.  In 2019, the GreyScan team was awarded the Eureka Prize for Research and Innovation. Established in 1990 to reward outstanding achievements in Australian science and science communication, the Eureka Prizes are Australia's most comprehensive national science awards.

Our team members have developed more than 45 different products across a variety of markets including security, healthcare, pharmaceutical and counter narcotics detection.

GreyScan's facility is located in Port Melbourne, Australia, where the R&D, production and entire HQ reside.  The business is scaling the production capacity of the ETD-100TM over the next two years to increase the build capacity from hundreds of units per annum, to thousands.  GreyScan is also partnered with contract manufacturing houses in the US to enable the product to be manufactured on US soil.





Board of Directors

Executive Team

Global Advisory Board